Aesthetic Medical International Holdings Group Limited (AIH) Research

Aesthetic Medical International Holdings Group Limited operates as a specialist in diverse cosmetic medical services. The company's comprehensive portfolio features various surgical aesthetic procedures, such as ophthalmic surgery, rhinoplasty, breast enlargement, and liposuction. Additionally, it offers non-surgical aesthetic treatments, which encompass minimally invasive techniques and energy-based therapies like laser, ultrasound, and ultraviolet light applications. Beyond these, the group provides a broader range of general healthcare and other beauty-focused medical services, including internal medicine, urology, gynecology, obstetrics, dental care, dermatological treatments, and solutions for hair loss. With operations spanning 15 treatment centers, its facilities are located across China, Hong Kong, and Singapore. The enterprise was founded in 1997 and its main office is situated in Shenzhen, People's Republic of China.

Market snapshot

Symbol
AIH
Price
$0.33
Day change
-33.19%
Market cap
$1.6M
P/E ratio
-0.03x
52-week range
0.287-1.43
Sector
Healthcare
Industry
Medical - Care Facilities

Peer companies

  • AlphaTON Capital Corp. (ATON)
  • Cano Health, Inc. (CANO)
  • Chembio Diagnostics, Inc. (CEMI)
  • COSCIENS Biopharma Inc. (CSCI)
  • Enzo Biochem, Inc. (ENZB)
  • Kineta, Inc. (KA)
  • Nymox Pharmaceutical Corporation (NYMXF)
  • Psychemedics Corporation (PMD)

Recent insider activity

  • SCHARLAU CHARLES E — A-Award (250 shares) on 2006-05-16

Open Aesthetic Medical International Holdings Group Limited (AIH) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.